Nabla Bio

We use AI to design antibodies for intractable diseases

Operating in healthcare based in Boston, MA, USA, Nabla Bio operates.

Profile

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

As a business in healthcare, Nabla Bio is listed here with the public details available about it.

Boston, MA, USA is where the company is located.

The company is listed at the Summer 2020 stage of development.

Recorded headcount: 8 employees.

Website: www.nabla.bio